HC Wainwright Reaffirms “Buy” Rating for Kamada (NASDAQ:KMDA)
Kamada (NASDAQ:KMDA – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report issued on Thursday,Benzinga reports. They presently have a $11.00 price objective on the biotechnology company’s stock. HC Wainwright’s price target would indicate a potential upside of 48.45% from the company’s current price. HC Wainwright […]
